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ABSTRACT 
Objective: To estimate prevalence of Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), 
Psoriatic Disease (PsD) and Crystal-Related Arthritis and healthcare use for inflammatory 
arthritis in First Nations and non-First Nations patients in Alberta, Canada.  
Methods: Population-based cohorts of adults with RA, AS, PsD and Crystal-Related Arthritis 
were defined, with First Nations determination by premium payer status, to estimate prevalence 
rates. Rates of outpatient primary care and specialist visits and hospitalizations (all-cause, 
inflammatory-arthritis specific) were estimated.  
Results: RA affected three times as many First Nations compared to non-First Nations residents 
(standardized rate ratio (SRR) 3.2, 95%CI 2.9 to 3.4). AS and PsD were more prevalent in First 
Nations (AS 0.6 per 100 residents, SRR 2.7, 95%CI 2.3 to 3.2; PsD 0.3 per 100 residents, SRR 
1.5, 95%CI 1.3 to 1.9), whereas crystal-related arthritis was less prevalent (SRR 0.7, 95%CI 0.6 
to 0.7). First Nations were more likely to have primary care visits (SRR 1.7, 95%CI 1.6 to 1.8) 
and less likely to have specialist visits (SRR 0.6, 95%CI 0.6 to 0.7) for RA relative to non-First 
Nations individuals. In PsD and crystal-related arthritis, First Nations people had higher rates of 
cause-specific hospitalizations. 
Conclusion: The estimated prevalence of RA, AS, and PsD was higher in the First Nations 
population while crystal-related arthritis was less prevalent compared to the non-First Nations 
population. First Nations people were more likely to see primary care physicians were and less 
likely to see specialists for inflammatory arthritis care.  
 
Key Indexing (MeSH) Terms: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, 
Psoriasis, Gout, Pseudogout, Epidemiology, Health Services Research, American Native 
Continental Ancestry Group 
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SIGNIFICANCE AND INNOVATION 
• The First Nations population of Alberta has increased prevalence of inflammatory 
arthritis conditions including rheumatoid arthritis (three times), ankylosing spondylitis 
(nearly three times) and psoriatic disease (one and a half times), compared to the general 
population, but a reduced prevalence of crystal-related arthritis (30% less). 
• First Nations were nearly twice as likely to have primary care visits and 40% less likely 
to have specialist visits for RA relative to non-First Nations individuals.  
• In psoriatic disease and crystal-related arthritis, First Nations people had higher rates of 
cause-specific hospitalizations.
Page 5 of 23
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
 6 
INTRODUCTION 
  Arthritis is the most prevalent chronic condition in Canada with substantial health burden 
and economic implications(1). First Nations populations in Canada may have excessive 
prevalence rates and higher disease severity of inflammatory arthritis conditions, as observed in a 
population-based study of rheumatoid arthritis (RA) in Manitoba, Canada(2) and a tertiary care 
centre study(3). Still, these findings are limited in the scope of inflammatory arthritis conditions.  
 A significant gap in the literature for both First Nations and non-First Nations populations 
in Canada relates to health care use for inflammatory arthritis, such as primary care physician 
visits, specialist visits, and hospitalizations(3, 4). For patients with inflammatory arthritis, 
optimal care requires access to specialist care from rheumatologists, orthopaedic surgeons and 
rehabilitation practitioners as well as access to medications and surgical procedures(5).  
Prevalence and health services use are two critical pieces of information required in order to 
effectively plan health service delivery to specific populations.    
 Using population-based data which permit determination of First Nations status, the 
primary objective of this analysis was to provide a single source for prevalence estimates of the 
inflammatory arthritis conditions (RA, ankylosing spondylitis (AS), Psoriatic Disease (PsD, 
including both psoriasis and psoriatic arthritis), and Crystal-related Arthritis (gout and 
pseudogout)) in the First Nations and non-First Nations populations of Alberta, Canada.  The 
second objective was to compare use of health services of primary care, specialty care and 
hospital services for inflammatory arthritis in the First Nations population to the general 
population. Identifying disparities in disease prevalence and healthcare use will provide a basis to 
target healthcare planning for specific populations who are in need of services to manage these 
chronic conditions.  
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METHODS 
Setting and Study Design: A cohort study was conducted using 4 comprehensive provincial 
health databases beginning in fiscal year 1993/1994 and including up to fiscal year 2010/2011: 
hospitalizations (the Inpatient Discharge Abstract Database), outpatient physician visits 
(Ambulatory Care, Practitioner Payments databases), and demographic information (Population 
Registry).  All administrative databases are maintained by Alberta Health for the Alberta Health 
Care Insurance Plan (AHCIP) including approximately 3.7 million residents. Databases were 
linked deterministically using the Alberta Provincial Health Number, the unique individual 
provincial identifier for healthcare, across all 4 databases. The number of individuals registered 
with AHCIP differs from national census data by only 0.1%(6).   
Case Determination: Arthritis case ascertainment was based on physician billing claims coded 
according to the 9
th
 International Classification of Diseases Clinical Modification (ICD-9-CM) 
system (minimum 1 code necessary, with up to 3 diagnoses fields allowed), or hospitalization 
data (16 discharge diagnoses fields with ICD-9-CM prior to April 2002, 25 discharge diagnoses 
fields with ICD-10-CA (International Classification of Diseases, 10
th
 Revision, Canadian 
Adaptation), after April 2002). Case definitions for each type of inflammatory arthritis were 
applied based on the work by Lix et al in RA(7, 8) with > 2 billing codes by any physician within 
2 years; or one hospitalization discharge diagnosis, used to define the prevalent cohort. The 
codes used were as follows: RA (ICD-9-CM 714.x, ICD-10-CA M05.x-M06.x); AS (ICD-9-CM 
720.x, ICD-10-CA M45.x); PsD (ICD-9-CM 696.0 and 696.1, ICD-10-CA M07.0-M07.3); 
Crystal-related Arthritis (ICD-9-CM 712.x and 274.x, ICD-10-CA M10.x and M11.x). Table 1 
includes detailed information on our case definitions. 
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Population Determination: First Nations status was based on a variable within the administrative 
data which has been developed by Alberta Health for health services research and adopted by the 
Alberta research community(9-11). This uses the provincial health premium payment history to 
identify individuals whose premiums were paid by the First Nations and Inuit Health Branch 
(Health Canada) at any time point since 1994, thus indicating Treaty Status as per the Indian Act. 
All others were classified as non-First Nations. According to AHCIP 3.7% of the 2007 Alberta 
population is First Nations, consistent with Statistics Canada census data(12). 
Main Outcomes and Statistical Analysis:  
Prevalence: All surviving individuals meeting the case definition during the run-in period 
(starting in 1993/1994) and registered with AHCIP at the midpoint of the 2008/2009 fiscal year 
constituted the prevalent population (numerator). The 2008/2009 fiscal year was selected for our 
estimates to ensure all potential cases identified through physician billing codes would be within 
a 2 year window at the end of the study period (2010/2011). The denominator was all registered 
individuals with AHCIP at the mid-point of the 2008/2009 fiscal year. Prevalence rates were 
stratified by First Nations status. Rates were standardized by age and sex using the direct method 
with the entire Alberta population as the reference. 
Health Care Use: 
i) Primary Care and Specialist Physician Visits. The Practitioner Payments database of Alberta 
Health captures all provincially reimbursed or shadow-billed physician visits. Primary care as 
well as specialist (in this study, rheumatologist or internist) visits were available in this database. 
We identified all visits by individuals meeting the case definitions, with the diagnostic code for 
the respective inflammatory arthritis condition in the primary position, indicating the primary 
reason for the visit. For each of the fiscal years between 2005/2006 and 2008/2009, the mean 
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number of outpatient arthritis-related visits for the prevalent cohort specifically to either a 
primary care physician or a specialist physician was calculated, by First Nations status and by 
urban/rural status. Standardized rate ratios were calculated with adjustment for age and sex 
relative to the Alberta population with that type of inflammatory arthritis. The rates for these 4 
fiscal years were averaged and expressed as a rate per 100 person-years with the inflammatory 
arthritis condition. 
ii) Hospitalization. Each individual separation in the Inpatient – Discharge Abstract Database for 
cohort members over the fiscal years 1997/1998 to 2010/2011 was counted as a unique all-cause 
related hospitalization; those members with a primary diagnosis field code for their respective 
inflammatory arthritis condition had each individual hospitalization counted as an arthritis-
specific hospitalization.  Average annual rates were expressed as a rate per 100 person-years with 
inflammatory arthritis, and stratified by First Nations status and urban/rural status.  Standardized 
rate ratios were calculated with adjustment for age and sex relative to the Alberta population 
specific for each type of inflammatory arthritis. 
Covariates: Demographic data including age, sex, and the first three digits of the postal code (to 
define rural or urban residence(13)) were extracted from the Population Registry. Validated case 
definitions for diabetes(14), hypertension(15), and Charlson comorbidities(16) were applied to 
classify comorbidities. All analyses were completed with SAS 9.4 and Excel 2013 (Microsoft 
Office). 
Ethics Approval: The University of Calgary Conjoint Research Health Ethics Board approved 
the study, following confirmation from the Alberta First Nations community that principles of 
Ownership, Control, Access and Possession were respected (Ethics ID E-23586). 
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RESULTS
 
Cohort Demographics: Table 2 summarizes the frequency of First Nations and non-First 
Nations individuals meeting the various inflammatory arthritis case conditions, by location of 
residence (urban or rural). In total, 38,931 individuals met the case definition for RA, 7,685 
individuals that met the case definition for AS, 6,040 individuals met the case definition for PsD, 
and 44,845 individuals met the case definition for crystal-related arthritis. The majority of 
individuals meeting the case definition for RA had at least one comorbidity (68.5% First Nations 
vs 64.6% non-First Nations), with First Nations individuals more frequently having diabetes 
compared to non-First Nations people (RA 10.7% vs 6.6%; AS 9.5% vs 4.7%; PsD 12.3% vs 
7.0%; Crystal-related arthritis 14.4% vs 10.5%). In RA, AS and crystal-related arthritis, 
hypertension was also more frequent in non-First Nations (RA 24.0% vs 13.4%; AS 15.5% vs 
10.1%; Crystal-related arthritis 39.5% vs 28.2%),  
Prevalence Rates and Standardized Rate Ratios (SRR): Overall and urban/rural prevalence 
rates which were standardized by age and sex for First Nations to the non-First Nations 
populations are reported, as are the SRR between populations (Table 3). The prevalence of RA 
was three-fold higher among First Nations residents (SRR 3.2, 95%CI 2.9 to 3.4) compared to 
non-First Nations residents. The prevalence of AS and PsD was also increased in First Nations 
people, with a SRR of 2.7 (95%CI 2.3 to 3.2) in AS and a SRR of 1.5 (95%CI 1.3 to 1.9) in PsD. 
The only type of inflammatory arthritis less prevalent in First Nations compared to non-First 
Nations populations was crystal-related arthritis (SRR 0.7, 95%CI 0.6 to 0.7), with a rate of 0.3 
per 100 residents, compared to 1.2 per 100 non-First Nations residents. The SRRs in RA and AS 
for First Nations compared to non-First Nations populations were higher in rural versus urban 
areas; no conclusion could be made in this regard for the other types of inflammatory arthritis.   
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Health Care Use, Outpatient Visits: Rates of primary care and specialist visits are presented in 
Table 4. In subjects meeting the case definition for RA, assessment of RA represented 12.6% of 
all visits to primary care for First Nations (mean 1.9, SD 5.2 primary care visits per year for RA) 
and 14.1% for non-First Nations (mean 1.3, SD 4.8 primary care visits per year for RA). In 
contrast, in patients with AS and PsD, these diagnoses accounted for <3% of primary care visits 
for both First Nations and non-First Nations and for patients with crystal-related arthritis, this 
diagnosis accounted for 5% of primary care visits in First Nations and 6.5% in non-First Nations.  
Visits to specialists for inflammatory arthritis conditions were higher in the non-First Nations 
population. After age and sex standardization, in those meeting the case definition for RA, First 
Nations patients were significantly more likely to have primary care visits for RA (SRR 1.7, 
95%CI 1.6 to 1.8) and less likely to have specialist visits for RA (SRR 0.6, 95%CI 0.6 to 0.7) 
relative to non-First Nations individuals (Figure 1), regardless of urban or rural residence. 
Similar trends for AS and PsD were also seen with primary care visits (AS SRR 1.3, 95%CI 1.1 
to 1.6; PsD SRR 1.5, 95%CI 1.1 to 1.9) and specialist visits (AS SRR 0.3, 95%CI 0.3 to 0.4; PsD 
SRR 0.6, 95%CI 0.4 to 0.7) with no clear differences seen between urban and rural residents. 
This indicates that in contrast to non-First Nations patients, those from First Nations 
communities are predominantly receiving their RA, PsD and AS care from primary care 
physicians rather than specialists. This is different from crystal-related arthritis, where First 
Nations patients were less likely to have any type of physician visit compared to non-First 
Nations (primary care SRR 0.5, 95%CI 0.4 to 0.6; specialist SRR 0.4, 95%CI 0.2 to 0.6). 
Health Care Use, Hospitalizations: First Nations patients with RA had twice the rate of all-
cause hospitalizations compared to non-First Nations patients, and slightly less likely to have an 
RA-related hospitalization compared to non-First Nations patients (Table 5). The SRR for all-
cause hospitalization rates was slightly higher in rural residents (rural SRR 2.1, 95%CI 1.9 to 2.4; 
Page 11 of 23
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
 12 
urban SRR 1.6, 95%CI 1.5 to 1.8), but not significantly different for arthritis-specific 
hospitalizations (SRR 0.9 95%CI 0.7 to 1.1 rural; SRR 0.8, 95%CI 0.7 to 0.9 urban). First 
Nations people with AS were also twice more likely than non-First Nations people to have an all-
cause hospitalization (SRR 2.1, 95%CI 1.7 to 2.5), although with no significant differences seen 
between rural and urban residents. AS-specific hospitalizations were numerically more common 
in First Nations people, prominently in urban residents, although with confidence intervals 
overlapping the null value. First Nations patients with PsD were three times as likely to have all-
cause hospitalizations and PsD-specific hospitalization, with a significantly greater difference in 
rural residents. First Nations patients with crystal-related arthritis were also nearly twice as likely 
to have all-cause hospitalizations and crystal-related arthritis specific hospitalization.  
For all types of inflammatory arthritis, diabetics had higher all-cause hospitalization rates 
compared to patients with any of the other Charlson comorbidities. Crude all-cause 
hospitalization rates for RA patients with diabetes were 73.3 (95%CI 70.0 to 76.9) and 46.2 
(95%CI 45.2 to 47.2) per 100 person-years for First Nations and non-First Nations patients 
respectively, in comparison to 44.0 (95%CI 43.0 to 45.0) and 28.7 (95%CI 28.4 to 28.9) for RA 
patients with any other Charlson comorbidity. Estimates were similar in AS, PsD and crystal-
related arthritis (data not shown). Hospitalization rates specifically for inflammatory arthritis 
were not clearly different in patients with diabetes or other comorbidities in either First Nations 
or non-First Nations cohorts, as the confidence intervals in many cases were overlapping. The 
only condition without overlapping confidence intervals was RA, with crude rates of condition-
specific hospitalization in diabetics being 2.0 (95%CI 1.4 to 2.6) and 3.9 (95%CI 3.6 to 4.2) per 
100 person-years for First Nations and non-First Nations patients respectively, in comparison to 
2.0 (95%CI 1.8 to 2.2) and 3.5 (95%CI 3.4 to 3.6) for any other Charlson comorbidity.  
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DISCUSSION 
 We contribute important new knowledge on the inflammatory arthritis burden and care 
gaps in the First Nations compared to the non-First Nations population in Alberta, Canada. 
Previously we have evaluated prevalence rates in First Nations of Alberta for osteoarthritis(17), 
systemic lupus erythematosus and scleroderma(18) and inflammatory myositis(19). In this 
current study, we present prevalence estimates for RA and AS, which were higher in the First 
Nations than the non-First Nations population, and PsD, which was similar in First Nations and 
non-First Nations groups.  Crystal-related arthritis (0.8%) was the only inflammatory arthritis 
condition with a lower prevalence in the First Nations population.  
 Prevalence estimates are one way of describing arthritis burden in a population; analysis 
of health services use reflects disease management needs arising from arthritis symptoms and 
complications. Prior to our study, a paucity of work on health services use for inflammatory 
arthritis conditions existed. Our earlier work based on Manitoba administrative data reported 
more claims to any provider for RA visits by First Nations (average 10/1000) compared to non-
First Nations (5/1000) residents (2). Although not specific to RA, significantly fewer follow-up 
visits annually in rheumatology clinics for Aboriginal patients (First Nations, Métis and Inuit) 
were reported(2). Our current analysis separates use by type of provider; First Nations patients 
were more likely to see primary care physicians for management of their inflammatory arthritis 
compared to non-First Nations, and were 40-70% less likely to see a rheumatology or internal 
medicine specialist for care, regardless of urban/rural status. For those with crystal-related 
arthritis, both primary and specialist care visits are occurring at reduced frequency for First 
Nations people. The specific reasons for these patterns were not possible to ascertain within our 
data sources, although availability of arthritis specialist providers outside of tertiary care centers 
is limited in our province. Another explanation relates to the clinical experiences of First Nations 
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patients when in contact with a tertiary healthcare system(20). Trust in the provider formed by 
positive relationships and the ease of accessibility to care may dominate the decision of 
remaining in primary care settings. Some have suggested that specialists may need to reframe 
their practice patterns and behaviours to similarly build trusting relationships(20). Since receipt 
of specialty care is linked to clinical arthritis outcomes(21) and provision of evidence-based 
therapy(22), the low rates of specialty visits among First Nations raises cause for concern, and 
suggests more quality-of-care work should be done in this regard.  
 Another burden of inflammatory arthritis is expressed by hospitalization rates. Higher 
rates of all-cause hospitalizations were reported in First Nations individuals across all types of 
inflammatory arthritis studied, although arthritis-specific hospitalization rates varied across 
diseases. Patients with PsD and crystal-related arthritis conditions had significantly higher all-
cause hospitalization rates for First Nations people, which was more pronounced for rural 
residents with PsD. A higher hospitalization rate may be reflective of a few situations, including 
the severity of disease requiring hospitalization, or arthritis comorbidity.  
 We have provided estimates of selected inflammatory arthritis reported in First Nation 
populations and provided insight into the burden of rheumatic conditions.  These estimates are 
based on administrative data which have inherent limitations and should be interpreted with 
caution(17, 18). We relied on previously used case definitions(7), however there is still potential 
for error in case ascertainment. Our provincial administrative datasets did not contain 
pharmacotherapy information during the period of study, which would have improved our case 
definition specificity if available. First Nations may have an increased likelihood of case 
ascertainment based on the frequency of use of primary care services, especially given the worse 
severity of disease demonstrated in other studies which we are unable to assess with our data 
source, which may have biased our estimates. We did however adjust for covariates available in 
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our datasets (age, sex, location of residence, comorbidity) to improve our estimates. We are also 
conscious that our estimates for the non-First Nations population reflects the population 
composition in our province, and that we cannot generate Caucasian-specific rates nor those of 
individual racial or ethnic groups, including the Métis population(23). In turn, the estimates 
based on Alberta data have uncertain generalizability to other tribal ancestry groups across the 
rest of Canada. National leadership to link First Nations and Métis registries to provincial 
administrative data would provide the ability to perform surveillance for the most prevalent 
chronic conditions affecting Indigenous populations, and contribute to a broader understanding 
of the impact of inflammatory arthritis in both in-patient and ambulatory care settings.  
CONCLUSION 
The prevalence estimates of inflammatory arthritis and evaluation of resulting health 
service needs in First Nations and non-First Nations populations of Alberta provide a basis for re-
assessing and enhancing existing arthritis care services.   
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Table 1. Case Definitions for Inflammatory Arthritis Conditions 
Inflammatory Arthritis 
Condition 
Codes  Source 
Rheumatoid Arthritis ICD-9-CM 714.x  
 
Physician claims, hospitalizations prior to April 
2002 
 
 ICD-10-CA M05.x-M06.x Hospitalizations after April 2002 
Ankylosing Spondylitis ICD-9-CM 720.x  
 
Physician claims, hospitalizations prior to April 
2002 
 
 ICD-10-CA M45.x Hospitalizations after April 2002 
Psoriatic Disease ICD-9-CM 696.0 and 696.1  Physician claims, hospitalizations prior to April 
2002 
 
 ICD-10-CA M07.0-M07.3 Hospitalizations after April 2002 
Crystal Related Arthritis ICD-9-CM 712.x and 274.x Physician claims, hospitalizations prior to April 
2002 
 
 ICD-10-CA M10.x and 
M11.x 
Hospitalizations after April 2002 
 
For all inflammatory arthritis conditions, the case definition was > 2 billing codes by any 
physician within 2 years OR one hospitalization discharge diagnosis 
Page 18 of 23
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
 19 
Table 2. Frequency of Inflammatory Arthritis Conditions in First Nations and non-First 
Nations Albertans by Urban and Rural Status in Fiscal Year 2008/2009 
 Total Cohort Urban Rural 
  First Nations non-First Nations First Nations non-First Nations 
Rheumatoid Arthritis 38,931 1,035 (38.7%) 29,136 (80.4%) 1637 (61.3%) 7,123 (19.6%) 
Ankylosing Spondylitis 7,685 132 (26.2%) 5,585 (77.8%) 371 (73.8%) 1,597 (22.2%) 
Psoriatic Disease 6,040 102 (48.1%) 4,861 (83.4%) 110 (51.9%) 967 (16.6%) 
Crystal Arthritis 44,845 297 (47.6%) 34,712 (78.5%) 327 (52.4%) 9,509 (21.5%) 
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Table 3. Prevalence Rates* per 100 population (95% Confidence Intervals) and 
Standardized Rate Ratios for First Nations relative to non-First Nations Populations  
 First Nations Population Non-First Nations 
Population 
Standardized Rate Ratio  
(First Nations: non-First 
Nations) 
 Overall Urban Rural Overall Urban Rural Overall Urban Rural 
Rheumatoid 
Arthritis 
3.2  
(3.1 to 
3.4) 
2.5  
(2.3 to 
2.7) 
3.9  
(3.7 to 
4.1) 
1.0  
(1.0 to 
1.0) 
1.0  
(0.9 to 
1.0) 
1.2  
(1.1 to 
1.2) 
3.2  
(2.9 to 
3.4) 
2.6  
(2.3 to 
2.9) 
3.2  
(2.9 to 
3.5) 
Ankylosing 
Spondylitis 
0.6  
(0.5 to 
0.6) 
0.3  
(0.2 to 
0.3) 
0.8  
(0.7 to 
0.9) 
0.2  
(0.2 to 
0.2) 
0.2  
(0.1 to 
0.2) 
0.3  
(0.2 to 
0.3) 
2.7  
(2.3 to 
3.2) 
1.4  
(1.0 to 
1.8) 
2.8  
(2.4 to 
3.4) 
Psoriatic 
Disease 
0.3  
(0.2 to 
0.3) 
0.3  
(0.2 to 
0.3) 
0.3  
(0.2 to 
0.3) 
0.2  
(0.1 to 
0.2) 
0.2  
(0.1 to 
0.2) 
0.2  
(0.1 to 
0.2) 
1.5  
(1.3 to 
1.9) 
1.6  
(1.2 to 
2.3) 
1.5  
(1.1 to 
1.9) 
Crystal 
Arthritis 
0.8  
(0.8 to 
0.9) 
0.9  
(0.7 to 
1.0) 
0.8  
(0.7 to 
0.9) 
1.2  
(1.2 to 
1.2) 
1.2  
(1.1 to 
1.2) 
1.6  
(1.5 to 
1.6) 
0.7  
(0.6 to 
0.7) 
0.7  
(0.7 to 
0.8) 
0.5  
(0.5 to 
0.6) 
 
* First Nations Rates Standardized to non-First Nations Population by Age and Sex; all estimates 
rounded to 1 decimal position 
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Table 4. Rates of Outpatient Visits per 100 person-years (95% Confidence Intervals) for 
Inflammatory Arthritis Conditions for First Nations relative to non-First Nations 
Populations  
 Primary Care Specialty Care 
 First Nations 
Population 
Non-First Nations 
Population 
First Nations 
Population 
Non-First Nations 
Population 
Rheumatoid 
Arthritis 
167.9 (161.7 to 
174.2) 
100.0 (99.0 to 101.1) 31.7 (28.6 to 34.8) 49.8 (49.0 to 50.6) 
Ankylosing 
Spondylitis 
28.5 (24.3 to 32.8) 21.6 (20.5 to 22.7) 12.1 (6.9 to 17.2) 37.1 (35.2 to 39.1) 
Psoriatic Disease 36.6 (28. 3 to 44.8) 24.9 (23.0 to 26.9) 14.9 (9.5 to 20.3) 26.8 (25.4 to 28.2) 
Crystal Arthritis 25.6 (23.0 to 28.1) 51.1 (45.9 to 56.4) 1.2 (0.6 to 1.9) 3.4 (2.7 to 4.2) 
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Table 5. Age and Sex Standardized Rate Ratios (95%CI) for Hospitalizations, First Nations 
vs non-First Nations Populations 
 Crude Rate Standardized Rate Ratio (95% CI) 
 First Nations 
Population 
non-First 
Nations 
Population 
Overall Urban Rural 
All-Cause Hospitalization 
Rheumatoid Arthritis 38.9 (38.2 to 39.7) 25.1 (24.9 to 25.3) 2.1 (1.9 to 2.2) 1.6 (1.5 to 1.8) 2.1 (1.9 to 2.4) 
Ankylosing Spondylitis 37.5 (35.8 to 39.2) 20.2 (19.9 to 20.6) 2.1 (1.7 to 2.5) 1.9 (1.4 to 2.5) 1.6 (1.3 to 1.9) 
Psoriatic Disease 36.8 (34.1 to 39.7) 17.9 (17.6 to 18.3) 3.0 (2.3 to 3.8) 1.4 (1.0 to 2.0) 3.2 (2.4 to 4.3) 
Crystal Arthritis 34.1 (32.5 to 35.7) 23.9 (23.7 to 24.1) 1.7 (1.5 to 1.9) 1.4 (1.1 to 1.7) 1.5 (1.3 to 1.8) 
Arthritis-Specific Hospitalization 
Rheumatoid Arthritis 2.3 (2.1 to 2.5) 3.4 (3.3 to 3.4) 0.8 (0.7 to 0.9) 0.8 (0.7 to 0.9) 0.9 (0.7 to 1.1) 
Ankylosing Spondylitis 1.0 (0.7 to 1.3) 1.3 (1.2 to 1.4) 2.7 (0.7 to 9.7) 4.5 (0.9 to 21.8) 0.6 (0.4 to 0.8) 
Psoriatic Disease 1.7 (1.2 to 2.4) 1.4 (1.3 to 1.5) 3.6 (1.1 to 11.9) 2.9 (0.3 to 31.1) 3.0 (1.4 to 6.6) 
Crystal Arthritis 1.6 (1.2 to 1.9) 1.6 (1.6 to 1.7) 2.1 (1.0 to 4.0) 2.0 (1.1 to 3.7) 1.4 (0.7 to 2.9) 
* age and sex standardized to general Alberta population with that type of inflammatory 
arthritis 
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Figure Legends: 
 
Figure 1. Age and Sex Standardized Rate Ratios (95%CI) for Outpatient Visits for each 
arthritis type, among those patients with that condition: First Nations vs non-First Nations 
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